Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Shah‐Jalal Sarker's publication output changed over time?
ScholarIQpublication output · 2007–2021
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2021.
1
1
1
1
1
1
1
3
1
200720122013201420152016201820192021
What are the most-cited papers on Shah‐Jalal Sarker?
ScholarIQmost cited works
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Peter Schmid, Jacinta Abraham, Stephen Chan, Duncan Wheatley, Adrian Murray Brunt, Gia Nemsadze, Richard D. Baird, Yeon Hee Park, Peter S Hall, Timothy Perren, Robert C. Stein, László Mangel, Jean-Marc Ferrero, Melissa Phillips, John Conibear, Javier Cortés, Andrew Foxley, Elza C. de Bruin, Robert McEwen, Daniel Stetson, Brian Dougherty, Shah‐Jalal Sarker, Aaron Prendergast, Max McLaughlin-Callan, Matthew Burgess, Cheryl Lawrence, Hayley Cartwright, Kelly Mousa, Nicholas C. Turner
Journal of Clinical Oncology. 2019393 CitationsOPEN ACCESS
A Randomized Prospective Study Comparing Acquisition of Laparoscopic Skills in Three‐Dimensional (3D) vs. Two‐Dimensional (2D) Laparoscopy
B. Alaraimi, W. El Bakbak, Shah‐Jalal Sarker, S. Makkiyah, Ahmad Almarzouq, Richie Goriparthi, Amina Bouhelal, Vincent Quan, Bijendra Patel
World Journal of Surgery. 2014123 Citations
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
Thomas Powles, Matthew Wheater, Omar Din, T. Geldart, Ekaterini Boleti, Andrew Stockdale, Santhanam Sundar, Angus Robinson, Imtiaz Ahmed, Akhila Wimalasingham, Wendy Burke, Shah‐Jalal Sarker, Syed A. Hussain, Christy Ralph
European Urology. 2015100 Citations
Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation
Vishal Vyas, Hazel Blythe, Elizabeth G. Wood, Balraj Sandhar, Shah‐Jalal Sarker, Damian Balmforth, Shirish G. Ambekar, John Yap, Steve Edmondson, Carmelo Di Salvo, Kit Wong, Neil Roberts, Rakesh Uppal, Ben G. Adams, Alex Shipolini, Aung Oo, David Lawrence, Shyam Kolvekar, Kulvinder Lall, Malcolm Finlay, M. Paula Longhi
JCI Insight. 202199 CitationsOPEN ACCESS
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
Thomas Powles, Alejo Rodríguez‐Vida, Ignacio Durán, Simon J. Crabb, Michiel Simon Van Der Heijden, Albert Font Pous, Gwénaëlle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, María José Méndez-Vidal, Cristina Suárez, Anja Lorch, Cora N. Sternberg, Mark Linch, Shah‐Jalal Sarker, Aaron Prendergast, Kelly Mousa, Daniel Castellano
Journal of Clinical Oncology. 201890 Citations
Related on ScholarIQ
Queen Mary University of London
Institution
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
Paper
A Randomized Prospective Study Comparing Acquisition of Laparoscopic Skills in Three‐Dimensional (3D) vs. Two‐Dimensional (2D) Laparoscopy
Paper
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer
Paper
Obesity and diabetes are major risk factors for epicardial adipose tissue inflammation
Paper
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
Paper